glp 1 novo nordisk GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article Earnings from Eli Lilly, Novo

"This new indication, based on the SOUL data, marks even further advancement and showcases the versatility of semaglutide while expanding options for millions of people." But all eyes are on another FDA decision that is slated to come by year-end: whether to approve oral semaglutide for obesity

Seino Y, Min KW, Niemoeller E, Takami A

This powerful prebiotic blend is best taken with Pendulum Akkermansia, a next generation beneficial gut bacteria, to increase its efficacy in protecting and healing your gut

We discussed the IGF-1 and cancer-surveillance conversation in the post on tesamorelin for visceral fat, and the same principles apply here

J Gastrointest Surg 5(4):547553